Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Sandoz prepares early 2019 launch for EpiPen alternative Symjepi at 16% discount
Fierce Pharma
Thu, 12/6/18 - 01:04 pm
Tags:
Novartis, Sandoz, generics, Symjepi, EpiPens, Teva Pharmaceutical, Mylan
Novartis, aiming to protect blockbuster sales, advances Xolair follow-up to phase 3
Fierce Pharma
Thu, 12/6/18 - 12:55 pm
Tags:
Novartis, Xolair, ligelizumab, hives, clinical trials
Novartis’ partners at Conatus have another NASH setback to confess today
Endpoints
Wed, 12/5/18 - 07:43 pm
Tags:
Novartis, Conatus, emricasan, cirrhosis, NASH, clinical trials
Novartis plots to retain hives patients with monoclonal antibody that outshines Xolair
Endpoints
Tue, 12/4/18 - 09:43 am
Tags:
Novartis, hives, monoclonal antibodies, ligelizumab, clinical trials
Novartis’ SMA Gene Therapy Is on the Fast Track for Approval
BioSpace
Mon, 12/3/18 - 05:55 pm
Tags:
Novartis, gene therapy, SMA, AVXS-101, Zolgensma, priority review, FDA
All in: Novartis adds another drug to its fast-growing radiopharmaceuticals division
Endpoints
Mon, 12/3/18 - 12:10 pm
Tags:
Novartis, oncology, FF-10158, radiopharmaceuticals, Fujifilm Toyama, Advanced Accelerator Application
ASH: Gilead, Novartis tout long-term data for CAR-T slow starters Yescarta, Kymriah
Fierce Pharma
Sun, 12/2/18 - 11:01 pm
Tags:
Gilead, Novartis, CAR-T, Yescarta, Kymriah, ASH2018
Novartis’ Gilenya gets approval in Europe to treat children and adolescents with MS
Pharmaceutical Business Review
Fri, 11/30/18 - 10:21 am
Tags:
Novartis, Gilenya, Europe, Relapsing Remitting Multiple Sclerosis
Novartis CEO Vas Narasimhan On The Price Of Gene Therapies: 'It's A Challenge We Have To Solve'
Forbes
Thu, 11/29/18 - 11:11 am
Tags:
Novartis, Pharma CEOs, Vas Narasimhan, gene therapy, AveXis
Novartis HQ is pulling up its roots in the UK and moving to a new biotech campus in London
Endpoints
Wed, 11/28/18 - 11:32 am
Tags:
Novartis, UK
Novartis/Spark’s sight gene therapy approved in EU
Pharmaforum
Fri, 11/23/18 - 01:16 pm
Tags:
Novartis, Spark Therapeutics, Luxturna, gene therapy, Europe
US benefits manager baulks after Novartis values gene therapy at $4-5 mln
Yahoo/Reuters
Fri, 11/23/18 - 01:12 pm
Tags:
Novartis, Express Scripts, SMA, spinal muscular atrophy, drug pricing, AVXS-101
A Small Group of Pharma Companies Is Making the Bulk of Medicines Necessary for Developing Countries
BioSpace
Fri, 11/23/18 - 01:08 pm
Tags:
GSK, JNJ, Novartis, Merck KGaA, Sanofi, Takeda, developing countries
Novartis confident in Gilenya despite FDA call out
Biopharma Dive
Wed, 11/21/18 - 01:09 pm
Tags:
Novartis, Gilenya, MS, multiple sclerosis
Novartis CEO Is Going All in With Some Big Bets on R&D
BioSpace
Wed, 11/21/18 - 12:18 pm
Tags:
Novartis, Pharma CEOs, Vas Narasimhan, R&D
Novartis focusing on cutting CAR-T costs ahead of EU launches
Pharmaforum
Tue, 11/20/18 - 11:51 am
Tags:
Novartis, CAR-T, Europe
Novartis' blood disorder drug gets FDA approval for expanded use
Reuters
Mon, 11/19/18 - 11:39 pm
Tags:
Novartis, Promacta, FDA, severe aplastic anemia
Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years
BioSpace
Mon, 11/19/18 - 11:29 am
Tags:
cancer, breast cancer, lung cancer, drug approvals, AstraZeneca, Takeda, Ariad Pharmaceuticals, Merck, Pfizer, Novartis, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Puma Biotechnology, Mylan, Genentech
Novartis’ CAR-T cancer drug available on NHS to young people
Pharmaforum
Sat, 11/17/18 - 12:34 pm
Tags:
Novartis, CAR-T, NHS, refractory B-cell acute lymphoblastic leukemia, Kymriah
It's Lights Out For Novartis And Verily's Glucose Monitoring 'Smart Lens' Project
Forbes
Fri, 11/16/18 - 07:57 pm
Tags:
Novartis, Alcon, Verily, Alphabet, blood glucose monitoring, devices, diabetes

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.